Contributions to Hypertension With Androgen Deprivation Therapy

计划入组 10 人 · 首次发布于 2023 年 1 月 26 日

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

计划入组 102 人 · 首次发布于 2008 年 10 月 21 日

Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy

计划入组 200 人 · 首次发布于 2015 年 12 月 16 日

Relugolix(Myfembree, Orgovyx, Ryeqo)

C₂₉H₂₇F₂N₇O₅S · Rx

Androgen

Darolutamide(Nubeqa)

C₁₉H₁₉ClN₆O₂ · Rx

Arvinas Androgen Receptor, Inc.

United States

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

ARANOTE Trial: Darolutamide Plus ADT Improves Outcomes in Metastatic Hormone-Sensitive Prostate Cancer

Meta-Analysis Reveals Optimal Androgen-Deprivation Therapy Duration for Localized Prostate Cancer Treatment

Studies Reveal Quality of Life Trade-offs with Androgen Deprivation Therapy in Prostate Cancer Treatment